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Adenovirus (AdV) is recognized increasingly as an
emerging pathogen causing relevant morbidity and
mortality after allogeneic hematopoietic stem cell
transplantation (allo-SCT), especially in pediatric and
T cell-depleted allo-SCT recipients [1]. Recent prog-
ress has been focused on the importance of monitoring
of plasmaAdVDNA loads, which enables early diagno-
sis, prediction of disseminated disease, and evaluation
of antiviral therapies [2,3].However, the epidemiologic
and virologic details about AdV serotypes and infection
mode are still not well understood. Recently, system-
atic analysis of AdV serotypes after SCT has revealed
sequential occurrence of multiple AdV serotype infec-
tions in pediatric allo-SCT recipients [4]. Here, we re-
port an adult case of severe disseminated AdV disease
by concurrent infection of 2 AdV serotypes, AdV 3
and AdV 34, after allo-SCT for myelodysplastic syn-
drome (MDS) with autoimmune hepatitis (AIH). The
clinical relevance of multiple AdV infections is dis-
cussed.
A 35-year-old female was diagnosed as having
MDS of refractory anemia with excess of blast-2
(RAEB-2). Interestingly, the blasts were character-
ized as B lineage lymphoblasts by the cell surface
marker expression pattern and the IgH clonal rear-rangement. Six months after the diagnosis, she devel-
oped AIH with progressive neutropenia and an
increment of lymphoblasts. After 0.75 mg/kg/day
of prednisolone (PSL) administration, both AIH
and hematologic abnormalities were remarkably im-
proved, suggesting that AIH should be a paraneoplas-
tic autoimmune phenomenon. To the best of our
knowledge, AIH is firstly described as an MDS-asso-
ciated autoimmune disorder. Lymphoid involvement
is also a rare event in MDS [5], and might cause a pe-
culiar immune derangement attributable to the de-
velopment of AIH.
Four months later, she received a bone marrow
transplantation (BMT) from anHLA 5/6-matched un-
related donor following conditioning with cyclophos-
phamide (CY) and 12 Gy of fractionated total body
irradiation (TBI). Graft-versus-host disease (GVHD)
prophylaxis consisted of cyclosporine (CsA) and a short
course of methotrexate (MTX). After engraftment on
the day 24, gross hematuria appeared and followed by
bilateral hydronephrosis and renal failure (Figure 1).
The rapid immunochromatography test detected
AdV in her urine. On the day 34, she was admitted to
the intensive care unit, because of severe respiratory,
cardiac, and renal failure. CsA was replaced with
0.5 mg/kg/day of PSL because of renal failure. AdV
was detected in blood and bronchoalveolar lavage fluid
(BALF) by polymerase chain reaction (PCR) analyses,
and blood plasma AdV DNA load was 5  106 copies/
mL, which was detected by real-time quantitative
PCR as previously described [2,6]. Ganciclovir was
continuously used, because cidofovir is unapproved
for use in Japan. Anti-AdV high-titer intravenous im-
munoglobulin was also administered, and PSL was
rapidly reduced with no signs of acute GVHD. Around
day 45, however, hemorrhagic colitis and severe hepati-
tis appeared. Continuation of intensive supportive careFigure 1. Clinical and virologic course after bone marrow transplantation. Abbreviations: WBC, white blood cells; Lym, lymphocytes; CsA,
cyclosporine; PSL, prednisolone;HC,hemorrhagic cystitis; CHDF, continuous hemodiafiltration;HD, hemodialysis;MV,mechanical ventilation.
354 Letters to the EditorTable 1. Sequences of Serotype-Specific Primer Sets for PCR Detection of Some AdV Serotypes
Serotype
(Subspecies) GenBank ID
Region
Gene/Product
Oligonucleotide Squence
50-Forward-30/ 50-Reverse-30
PCR Product
Size (bp)
AdV (qRT-PCR) NC001405 Hexon protein AD185S / AD185A: 50-tccagcaacttcatgtccatgg-
30/ 50-tcgatgacgccgcggt-30
TaqMan probe: 50-(FAM)-
cccatggacgagcccaccct-(TAMRA)-30
AdV 1 (C) AF534906 L4/hexon protein Outer (1st): 50-ttctgatacccaaactgaaggcaatcc-
30/50-gttttgcttggtttgtatgaaatgtgagtatcag-30
369
Inner (2nd): 50-tttttgccgatcccacttatcaacc-30/
50-tgctactagtataccttgaccccca-30
176
AdV 2 (C) J01917 L4/hexon protein Outer (1st):
50-gctacaaataggatcagacaatgcagaa-30/ 50-
cacttttggtttagtagcattgccttg-30
319
Inner (2nd):
50-cagtggaacgaagctgatgctaatgcgg-30/ 50-
agaggcacccctttttcatccgg-30
149
AdV 3 (B1) AY599834 L3/hexon protein Outer (1st):
50-tacaacaaatggggacaatgcagtaact-30/ 50-
agtttcaacccctccttcggt-30
352
Inner (2nd):
50-caaattgggaaagacattaccactactgaag-30/ 50-
cccccttttatgtttgtaggtcttgc-30
209
AdV 5 (C) AY601635 L3/hexon protein Outer (1st):
50-ttaaggaaggtaactcacgagaactaatgg-30/ 50-
gtctctgtattaatcacacctcccagt-30
358
Inner (2nd):
50-ggaaggtaactcacgagaactaatgggcc-30/ 50-
ccgccagaacacccatattacccgt-30
128
AdV 7 (B1) AY594255 L3/hexon protein Outer (1st):
50-atagttacagcaggagaagaaagagcagt-30/ 50-
acatctccttcggttggttttacttttct-30
338
Inner (2nd): 50-aaagacattactgcagacaacaagccc-
30/50-gctggtttaagagctctacctccaaa-30
134
AdV 11 (B2) AF532578 L3/hexon protein Outer (1st):
50-aatacaactggtgaggaacacgtaacag-30/ 50-
ccgcatcaaaaaactccatgtcgatatcat-30
388
Inner (2nd):
50-tggaagtttcagatgaagaaagtaaaccga-30/50-
caaaggacccgtagcatggtttc-30
168
AdV 34 (B2) AY737797 L3/hexon protein 50-gaaggtcctaaaccaatctatg-30/ 50-
gatgttgttagtgccatcg-30
225
AdV 35 (B2) AY271307 L3/hexon protein 50-atgaaacagaggagaaaactg-30/ 50-
agatgggtttagattcgtttt-30
129gradually improved her conditions with a slow restora-
tion from lymphopenia, and a reduction of AdV DNA
load. AdV DNA in plasma became undetectable on
day 67, and hemodialysis and mechanical ventilation
were finally withdrawn. She maintained wellness with
complete remission 1 year after BMT.
Among Japanese adult recipients, AdV 11 (Species
B) is most commonly incriminated as hemorrhagic
cystitis [6], which rarely causes severe AdV disease.
We thus performed PCR-based AdV serotyping. Sero-
type-specific primer sets were designed on the hexon
regions of 8 AdV serotypes (AdV 1, 2, 3, 5, 7, 11, 34,
and 35). Nested PCR analyses were executed using
outer and inner primers for detection of AdV 1, 2, 3,
5, 7, and 11. The sequences of the primers are summa-
rized in Table 1. As a consequence, we identified 2 se-
rotypes, AdV 3 (subspecies B1) and 34 (subspecies B2),in both blood and BALF around days 35-50, whereas
AdV 1, 2, 5, 7, 11 and 35 were not detected.
Adenoviruses are subdivided into 6 subspecies and
51 serotypes. Especially, species B and C have been
the major causes of AdV infections in allo-SCT recip-
ients, but some regional or racial differences exist in
epidemiologic serotype distribution [6-8]. AdV sero-
typing is not necessarily required for the diagnosis
of AdV infection, and has been performed only in lim-
ited cases. Recently, a sustained analysis of AdV sero-
types demonstrated sequential emergence of multiple
AdV serotypes among pediatric recipients who under-
went allo-SCT [4]. More than 1 serotype could be
detected sequentially in 36% of AdV infections after
allo-SCT. Additionally, single serotype infections
had a lower survival rate than multiple serotype infec-
tions, most of which were continually observed in
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dysfunction. This study depicted the complex nature
of AdV infection after allo-SCT.
On the other hand, the clinical relevance of multi-
ple infections has not been investigated so far in adults.
Coinfection of AdV species B and C was also observed
in adult recipients [8], and none of the cases with B and
C species viremia showed serious infectious complica-
tions. We added a new case of mixed infection, in
which 2 AdV serotypes, AdV3 and AdV34, were iden-
tified by serotype-specific PCR analyses. Our case has
been narrowly rescued, but the severity was quite
extensive and differs from the favorable outcome of
either sequential AdV infections in pediatric recipi-
ents, or mixed AdV viremia in adult recipients. A pro-
longed immunocompromised state due to MDS
with the lymphoid abnormality and pre-BMT immu-
nosuppressive therapy to AIH may attribute to both
multiple AdV infections and the severe clinical course.
The clinical importance of multiple AdV infections
may depend on several factors such as patient popula-
tions, underlying diseases, stem cell sources, GVHD
statuses, and AdV serotypes.
Ribavirin is 1 of the treatment options of AdV dis-
ease, but the clinical response varied considerably in
contrast to cidofovir. Considering that antiviral activ-
ity of ribavirin is relatively specific for AdV species C
and highly serotype-dependent [9], this type of infec-
tion might contribute to the variable outcome of riba-
virin therapy. Moreover, this phenomenon would be
important for verifying the role of reactivation of latent
or persistent viruses in AdV infection after allo-SCT
and development ofmore efficient immunotherapeutic
interventions. Serotype-specific PCR analysis per-
formed in this case may be useful for validation of
this mode of infection as well as other genotypic anal-
yses [10,11]. Further investigation of simultaneous
and/or sequential AdV infections could provide new
insights about the pathogenesis and management of
AdV infections after allo-SCT.
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